We’ve just released a new funding opportunity announcement (FOA) soliciting applications for the Diversity Program Consortium’s Sponsored Programs Administration Development (SPAD) Program (UC2).
A primary goal of the program is to enhance faculty and student participation in biomedical research and research training programs. These programs include undergraduate research programs, Academic Research Enhancement Awards (R15), and Support of Competitive Research (SC1, SC2, SC3), among others. Funded institutions are expected to develop offices that provide services such as professional development in targeted areas (e.g., enhancing grant-writing skills), pre- and post-award services, and certification-guided training of sponsored program staff and leadership.
Continue reading “Funding Opportunity: Sponsored Programs Administration Development (SPAD) Program and Webinar”
As announced earlier in the fiscal year, NIGMS is offering administrative supplements to NIGMS-funded R01, R35, and R37 awards for the purchase of single pieces of equipment.
The deadline for these supplement applications has been extended to June 25, 2019.
Continue reading “Extended Deadline to June 25: NIGMS Administrative Supplements for Equipment”
Prospective applicants frequently ask us whether their application ideas fit within our mission. NIGMS supports basic research that increases our understanding of biological processes and lays the foundation for advances in disease diagnosis, treatment, and prevention. We also support research in some specific clinical areas that affect multiple organ systems, including anesthesia, sepsis, wound healing, and trauma. In addition, we’re committed to training the next generation of scientists, enhancing the diversity of the scientific workforce, and developing research capacity throughout the country.
Not all applications for fundamental biomedical research projects will ultimately be assigned to NIGMS. Other NIH institutes and centers (ICs) also have strong commitments to basic research that underlie an understanding of their own particular organ systems, diseases, or treatments. Each NIH IC is different and supports distinct research areas, so it’s wise to seek advice from the program where your science best fits. Before submitting an application to NIGMS, we strongly recommend that you contact the program director whose portfolio most closely matches your area of research.
Continue reading “Does your application fit the scientific mission of NIGMS?”
NIGMS, along with 11 other NIH institutes and centers, is seeking Small Business Innovation Research (SBIR) applications to develop methods that improve the reproducibility of human induced pluripotent stem cell (iPSC) derivation, growth, and differentiation (RFA-GM-19-001). Human iPSCs are mature cells that have been reprogrammed to an embryonic stem cell-like state and are able to differentiate into any cell type in the body. iPSCs are increasingly important research systems with a wide variety of applications, including studies of human development, tissue regeneration and repair, disease processes, and the development of new therapeutics. iPSCs and other regenerative technologies also have potential to transform clinical practice by creating living, functional tissues to repair or replace tissues or organs lost due to age, disease, damage, or congenital defects. Realizing the full potential of human iPSCs for both research and clinical practice has been limited by the significant variability in reprogramming efficiency, differentiation potential, and cell growth and stability. This funding opportunity announcement (FOA) will support SBIR projects to develop novel, reliable, and cost-effective methods to standardize and increase the utility and reproducibility of iPSCs at all stages, from their derivation to their research and clinical applications.
Continue reading “Funding Opportunity: Methods to Improve Reproducibility of iPSC Derivation, Growth, and Differentiation”
For the past few months, NIGMS has been reviewing its HIV/AIDS grant portfolio. As the HIV/AIDS field has matured and the necessary research directions have become clearer, the HIV/AIDS-related grants we’ve supported have, appropriately, become more narrowly focused. Because of this, and after close consultation with leadership at the National Institute of Allergy and Infectious Diseases (NIAID), we’ve concluded that it’s in the best interest of the research to transition NIGMS’ HIV/AIDS portfolio to NIAID to allow improved scientific coordination, prioritization, and efficiency of management.
Continue reading “NIGMS-Managed HIV/AIDS Research Transitioning to NIAID”
UPDATE: The slides [PDF, 1.42MB] and video from the R01/R21 Webinar have been posted.
We’ve just re-issued two funding opportunity announcements (FOAs) for technology research and development grants that support biomedical research areas within the NIGMS mission.
Exploratory Research for Technology Development (R21)
Two-year grants that support innovative, high-risk concepts for developing a new technology or radically improving an existing one. The R21 supports only novel concepts that haven’t yet been tested for feasibility. Thus, unpublished data are not allowed. Because proof of concept must not already be developed, NIGMS expects the projects to be high risk.
Next application receipt
date: June 16, 2019
Focused Technology Research and Development (R01)
Four-year grants that support development projects to validate and optimize a new technology. The R01 is for technologies that already have been shown to be feasible but need further technical work to produce a useful prototype. Projects with partial demonstration of feasibility but with substantial risk remaining could be submitted as a 3-year R01 with a reduced budget under this FOA.
application receipt date: June 5, 2019
Continue reading “Funding Opportunity: NIGMS Technology Research and Development”
UPDATE: The slides from the U-RISE [PDF, 948KB] and MARC [PDF, 1.1MB] webinars have been posted.
In May 2018, we shared with you our plans to reorganize the undergraduate and graduate programs in the Division of Training, Workforce Development, and Diversity. As part of this reorganization, in December we announced two new graduate training programs. Now, we are pleased to announce two new undergraduate funding opportunities aimed at developing and implementing effective, evidence-based approaches to biomedical training and mentoring. The goal of these funding announcements is to enhance diversity in the biomedical research workforce and to encourage applications from training programs that:
Continue reading “New Undergraduate Training Programs Announced”
NIGMS has published a Notice in the NIH Guide to clarify the types of conferences and scientific meetings that the Institute will support through the R13 activity code. If you are thinking of requesting NIGMS funding for a meeting, it’s important to know that:
Continue reading “Clarification About Support for Conferences and Meetings”
At the recent NIGMS Advisory Council meeting, the Division of Training, Workforce Development, and Diversity received approval to write two new funding opportunity announcements as part of our efforts to enhance postdoctoral career transitions to promote faculty diversity in the biomedical research workforce.
Watch the MOSAIC presentation at the January Advisory Council meeting.
The Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) program is designed to facilitate the transition of talented postdoctoral researchers from diverse backgrounds into independent faculty careers in research-intensive institutions. The program has two components: an institutionally-focused research education cooperative agreement (UE5) and postdoctoral career transition award (K99/R00) to enhance diversity. Continue reading “Early Notice: Concept Clearance for the Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Program (UE5 and K99/R00) to Promote Diversity in the Biomedical Research Workforce”